NXSCF (Next Science) Accounts Payable & Accrued Expense : $2.66 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Accounts Payable & Accrued Expense?

Next Science's quarterly accounts payable & accrued expense declined from Dec. 2023 ($3.21 Mil) to Jun. 2024 ($3.11 Mil) and declined from Jun. 2024 ($3.11 Mil) to Dec. 2024 ($2.66 Mil).

Next Science's annual accounts payable & accrued expense increased from Dec. 2022 ($1.98 Mil) to Dec. 2023 ($3.21 Mil) but then declined from Dec. 2023 ($3.21 Mil) to Dec. 2024 ($2.66 Mil).

Next Science Accounts Payable & Accrued Expense Historical Data

The historical data trend for Next Science's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Accounts Payable & Accrued Expense Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.06

1.17

1.98

3.21

2.66

Next Science Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial								1.98	3.32	3.21	3.11	2.66

Next Science Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Next Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (OTCPK:NXSCF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NXS:Australia

Address

264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.